Robert Baldi

706 total citations
8 papers, 476 citations indexed

About

Robert Baldi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Robert Baldi has authored 8 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Robert Baldi's work include Cancer, Hypoxia, and Metabolism (3 papers), ATP Synthase and ATPases Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). Robert Baldi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), ATP Synthase and ATPases Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). Robert Baldi collaborates with scholars based in United States. Robert Baldi's co-authors include Donald P. McDonnell, Jason W. Locasale, Xiaojing Liu, Jeffrey C. Rathmell, Sung Hee Park, Suzanne E. Wardell, Rachid Safi, Ching‐yi Chang, Peng Liu and Jeff S. Jasper and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Cell Metabolism.

In The Last Decade

Robert Baldi

8 papers receiving 468 citations

Peers

Countries citing papers authored by Robert Baldi

Since Specialization

Citations

This map shows the geographic impact of Robert Baldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Baldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Baldi more than expected).

Fields of papers citing papers by Robert Baldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Baldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Baldi. The network helps show where Robert Baldi may publish in the future.

Co-authorship network of co-authors of Robert Baldi

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Baldi. A scholar is included among the top collaborators of Robert Baldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Baldi. Robert Baldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer 2020 ·Breast Cancer Research and Treatment ·(unknown), Suzanne E. Wardell, (unknown), (unknown), Robert Baldi, Christina Chao, (unknown), (unknown), Rui Xiong, Debra A. Tonetti, (unknown), Jiong Zhao, Jessica A. Sorrentino, (unknown), John Bisi, Jay C. Strum, Gregory R. J. Thatcher, John D. Norris	37
2	Inhibition of ERRα Prevents Mitochondrial Pyruvate Uptake Exposing NADPH-Generating Pathways as Targetable Vulnerabilities in Breast Cancer 2019 ·Cell Reports ·Sung Hee Park, Rachid Safi, Xiaojing Liu, Robert Baldi, Wen Liu, Juan Liu, Jason W. Locasale, Ching‐yi Chang, Donald P. McDonnell	41
3	A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product 2017 ·Cell Metabolism ·Maria V. Liberti, Ziwei Dai, Suzanne E. Wardell, Joshua A. Baccile, Xiaojing Liu, Xia Gao, Robert Baldi, Mahya Mehrmohamadi, Marc O. Johnson, Neel S. Madhukar, Alexander A. Shestov, Iok In Christine Chio, Olivier Elemento, Jeffrey C. Rathmell, Frank C. Schroeder, Donald P. McDonnell, Jason W. Locasale	143
4	Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer 2017 ·Journal of Clinical Investigation ·John D. Norris, Stephanie J. Ellison, (unknown), David B. Stagg, Suzanne E. Wardell, Sung Hee Park, Holly M. Alley, Robert Baldi, (unknown), (unknown), James P. Stice, Scott A. Lawrence, Joel R. Eisner, Douglas K. Price, William R. Moore, William D. Figg, Donald P. McDonnell	38
5	Abstract 5641: Effects of G1T48, a novel orally bioavailable selective estrogen receptor degrader (SERD), and the CDK4/6 inhibitor, G1T38, on tumor growth in animal models of endocrine resistant breast cancer 2017 ·Cancer Research ·Suzanne E. Wardell, (unknown), (unknown), Robert Baldi, (unknown), Jessica A. Sorrentino, John Bisi, Jay C. Strum, John D. Norris	14
6	ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer 2016 ·Cell Reports ·Sung Hee Park, Ching‐yi Chang, Rachid Safi, Xiaojing Liu, Robert Baldi, Jeff S. Jasper, Grace R. Anderson, Tingyu Liu, Jeffrey C. Rathmell, Mark W. Dewhirst, Kris C. Wood, Jason W. Locasale, Donald P. McDonnell	112
7	Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease 2015 ·Journal of Leukocyte Biology ·(unknown), Mengyao Jin, Michael F. Weeks, Rishi R. Rampersad, Robert Baldi, (unknown), Yajuan Shen, Denise Esserman, (unknown), Todd A. Schwartz, Peng Liu	88
8	Myeloid-derived suppressor cells ameliorate the pathogenesis of autoimmune arthritis (P1058) 2013 ·The Journal of Immunology ·(unknown), (unknown), Rishi R. Rampersad, Robert Baldi, Peng Liu	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact